87 studies found for:    Open Studies | "Urinary Bladder, Overactive"
Show Display Options
Rank Status Study
21 Not yet recruiting Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Older Adult Subjects With Overactive Bladder (OAB)
Condition: Overactive Bladder (OAB)
Interventions: Drug: Mirabegron;   Drug: Placebo
22 Unknown  Cystoscopy Plus Urethral Dilatation Versus Cystoscopy Alone in Women With Overactive Bladder Syndrome and Impaired Voiding
Conditions: Overactive Bladder Syndrome;   Voiding Dysfunction
Interventions: Procedure: Cystoscopy;   Procedure: Cystoscopy and urethral dilatation
23 Recruiting A Study to Evaluate Tolerability and Patient Preference Between Myrbetriq® and Detrol® LA in Subjects With Overactive Bladder (OAB)
Condition: Overactive Bladder (OAB)
Interventions: Drug: Myrbetriq;   Drug: Detrol LA
24 Recruiting A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Mirabegron OCAS (Oral Controlled Absorption System) in Pediatric Subjects With Neurogenic Detrusor Overactivity or Overactive Bladder
Conditions: Pharmacokinetics of Mirabegron;   Neurogenic Detrusor Overactivity;   Overactive Bladder
Intervention: Drug: Mirabegron
25 Unknown  A Randomized, Placebo-Controlled Study to Assess the Efficacy of Propantheline for the Treatment of Overactive Bladder
Condition: Overactive Bladder Associated With HTLV-1
Interventions: Drug: Propantheline Bromide;   Drug: Placebo
26 Recruiting Post-treatment Novmalized Urodynamiz Findings as the Golden Standard of Objective Cure for Female Overactive Bladder Patients Receiving Antimuscarinic Drug
Condition: Overactive Bladder Syndrome
Intervention: Drug: Solifenacin
27 Recruiting Biowave Overactive Bladder Trial
Condition: Overactive Bladder
Intervention: Device: Biowave Treatment
28 Unknown  Pilot Study: Is Overactive Bladder Caused by Subacute Urinary Tract Infections?
Condition: Overactive Bladder
Intervention:
29 Unknown  Validation of Instruments for Pragmatic Clinical Trials for Overactive Bladder
Condition: Overactive Bladder
Intervention: Drug: Toviaz
30 Not yet recruiting Educating Patients on Management of Overactive Bladder: Written Versus Verbal Instructions
Condition: Overactive Bladder
Intervention: Other: Written List
31 Recruiting "The Effects of Caffeine on Overactive Bladder Symptoms and Mental Health in Postmenopausal Women"
Conditions: Overactive Bladder;   Caffeine;   Menopause
Interventions: Dietary Supplement: 400 mg of caffeine/day (Two 200mg pills/day);   Dietary Supplement: 200 mg of caffeine/day (One 200mg pill and one placebo pill);   Dietary Supplement: Two placebo pills/day
32 Recruiting Different Injection Number of the Same Dose of Botulinum Toxin A on Overactive Bladder Syndrome
Condition: Overactive Bladder
Interventions: Drug: BoNT-A (10 injection);   Drug: BoNT-A (20 injection);   Drug: BoNT-A (40 injection)
33 Unknown  Botox for the Treatment of Overactive Bladder Secondary to Benign Prostatic Obstruction
Condition: Overactive Bladder
Intervention: Drug: Botox/Placebo
34 Unknown  Interventions to Enhance Medication Persistence and Compliance in Patients With Overactive Bladder
Condition: Overactive Bladder
Intervention: Behavioral: Health education intervention (HEI)
35 Recruiting Urinary Nerve Growth Factor (NGF), Prostaglandin E2 (PGE2)and Adenosine Triphosphate (ATP): Potential Biomarkers in Overactive Bladder Patients
Condition: Overactive Bladder
Intervention: Drug: Oxybutinin, Fesoterodine, Solifenacin, Propiverin, Trospium
36 Recruiting Secondary Bilateral Sacral Nerve Stimulation in Overactive Bladder Patients
Condition: Bladder Hyperactivity
Intervention: Device: Device:   INTERSTIM II
37 Recruiting Comparison of Posterior Tibial Nerve Electrical Stimulation Protocols for Overactive Bladder Syndrome
Condition: Overactive Bladder Syndrome
Interventions: Device: TENS 1-1;   Device: TENS 1-2;   Device: TENS 2-2;   Device: TENS 0-1
38 Unknown  The Effect of Position on Urge Sensation in Volunteers and in Patients With Overactive Bladder Syndrome
Condition: Overactive Bladder Syndrome
Intervention:
39 Recruiting OnabotulinumtoxinA for the Treatment of Urinary Incontinence Due to Overactive Bladder in Pediatric Patients
Conditions: Urinary Incontinence;   Urinary Bladder, Overactive
Intervention: Biological: OnabotulinumtoxinA
40 Recruiting An Observational Study of BOTOX® for the Management of Urinary Incontinence in Patients With Idiopathic Overactive Bladder
Conditions: Urinary Incontinence;   Urinary Bladder, Overactive
Intervention: Biological: botulinum toxin Type A

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years